A Valuation and Partnering Approach for Pre-Commercial Biotechnology Programs

Presented by

Julian Snow

About this talk

This session will outline how to determine a risk adjusted net present value for a pre-commercial biotech using @RISK to sensitize inputs and derive outputs. There will also be a review of how to link to potential partnership scenarios.

Related topics:

More from this channel

Upcoming talks (1)
On-demand talks (227)
Subscribers (49887)
Palisade Company is the world’s leading provider of risk and decision analysis software solutions for science and industry. Our array of software products and custom services enhance the management experience by combining the latest in cutting-edge technology with over 35 years of analytics experience. Palisade’s unified software platform helps clients increase margins, improve performance, expand market share, and maximize operational efficiencies. We have a very simple mission: to minimize risk while maximizing potential.